Figure 16, Standardized mean change from baseline to end of treatment in PTSD symptoms for narrative exposure therapy compared with inactive controls - Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update

Warning: The NCBI web site requires JavaScript to function. more...

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Forman-Hoffman V, Middleton JC, Feltner C, et al. Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 May. (Comparative Effectiveness Review, No. 207.)

Cover of Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update

Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update [Internet].

Show details

Contents

Figure 16 is titled “Standardized mean change from baseline to end of treatment in PTSD symptoms for narrative exposure therapy compared with inactive controls. The figure displays a forest plot reporting standardized mean difference in PTSD symptoms as measured by the PDS, narrative exposure therapy compared with inactive controls. This figure is described further in the “PTSD Symptoms” section as follows: “All three trials that compared NET with an inactive comparator found that NET subjects had greater decreases in PTSD symptoms at the end of treatment (moderate SOE; Figure 16). One trial reported a reduction (but no data) in PTSD symptoms for subjects in the intervention group at the follow-up assessment 6 months after the end of treatment; another reported that the intervention lead to significantly greater decreases in PTSD symptoms than no treatment (i.e., monitoring group) from baseline to the 6-month follow-up (d=1.4 and 0.08, respectively, p<0.001).”

Figure 16Standardized mean change from baseline to end of treatment in PTSD symptoms for narrative exposure therapy compared with inactive controls

CI = confidence interval; NET = narrative exposure therapy; PDS = Posttraumatic Diagnostic Scale; SMD = standardized mean difference.

From: Results

Contents

Views

Cite this Page
Forman-Hoffman V, Middleton JC, Feltner C, et al. Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 May. (Comparative Effectiveness Review, No. 207.) Figure 16, Standardized mean change from baseline to end of treatment in PTSD symptoms for narrative exposure therapy compared with inactive controls.
PDF version of this title (6.4M)

Other titles in these collections

Recent Activity

Clear Turn Off Turn On

Figure 16, Standardized mean change from baseline to end of treatment in PTSD sy...
Figure 16, Standardized mean change from baseline to end of treatment in PTSD symptoms for narrative exposure therapy compared with inactive controls - Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update
294742[uid] (1)
Taxonomy
Homo sapiens MAGE family member D1 (MAGED1), transcript variant 2, mRNA
Homo sapiens MAGE family member D1 (MAGED1), transcript variant 2, mRNA
gi|1677498913|ref|NM_006986.4|
Nucleotide
"[198967-25-8]"[CompleteSynonym] (1)
PubChem Compound
AGENCOURT_39798911 NICHD_XGC_Te2N Xenopus laevis cDNA clone IMAGE:7767878 5', mR...
AGENCOURT_39798911 NICHD_XGC_Te2N Xenopus laevis cDNA clone IMAGE:7767878 5', mRNA sequence
gi|56706181|gnl|dbEST|26756093|gb|C 59.1|
Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on